Dr. Julien Allard is the founder and CEO of E-Phys, a french CRO specialized in preclinical electrophysiology in anaesthetised rodents.

He is a senior scientist with more than 10 years of experience as an academic researcher and in the drug discovery industry. Dr. Allard holds a Master’s Degree in biochemistry and Neuroscience, and a PhD in Neuroscience where he focused on pharmacology and molecular biology.

Dr. Allard worked for Pfizer Global Research and Development (in Sandwich, UK, from 2006 to 2011), where his work had strong emphasis on Pain drug development: he developed in vivo electrophysiology models in mice for various discovery programs.